Structure

Physi-Chem Properties

Molecular Weight:  722.35
Volume:  714.33
LogP:  -0.61
LogD:  -0.27
LogS:  -2.372
# Rotatable Bonds:  21
TPSA:  312.99
# H-Bond Aceptor:  18
# H-Bond Donor:  13
# Rings:  3
# Heavy Atoms:  18

MedChem Properties

QED Drug-Likeness Score:  0.056
Synthetic Accessibility Score:  5.121
Fsp3:  0.412
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.571
MDCK Permeability:  3.0520354812324513e-06
Pgp-inhibitor:  0.002
Pgp-substrate:  1.0
Human Intestinal Absorption (HIA):  0.939
20% Bioavailability (F20%):  0.999
30% Bioavailability (F30%):  1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.076
Plasma Protein Binding (PPB):  56.910037994384766%
Volume Distribution (VD):  0.892
Pgp-substrate:  44.195762634277344%

ADMET: Metabolism

CYP1A2-inhibitor:  0.001
CYP1A2-substrate:  0.049
CYP2C19-inhibitor:  0.034
CYP2C19-substrate:  0.052
CYP2C9-inhibitor:  0.02
CYP2C9-substrate:  0.165
CYP2D6-inhibitor:  0.07
CYP2D6-substrate:  0.209
CYP3A4-inhibitor:  0.04
CYP3A4-substrate:  0.235

ADMET: Excretion

Clearance (CL):  1.809
Half-life (T1/2):  0.708

ADMET: Toxicity

hERG Blockers:  0.205
Human Hepatotoxicity (H-HT):  0.178
Drug-inuced Liver Injury (DILI):  0.984
AMES Toxicity:  0.023
Rat Oral Acute Toxicity:  0.236
Maximum Recommended Daily Dose:  0.427
Skin Sensitization:  0.181
Carcinogencity:  0.241
Eye Corrosion:  0.003
Eye Irritation:  0.003
Respiratory Toxicity:  0.791

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC170302

Natural Product ID:  NPC170302
Common Name*:   Anchinopeptolide A
IUPAC Name:   (2S,3R,4S)-3-[2-(diaminomethylideneamino)ethyl]-4-[3-(diaminomethylideneamino)propyl]-2,4-dihydroxy-N,1-bis[(2S)-1-[[(E)-2-(4-hydroxyphenyl)ethenyl]amino]-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide
Synonyms:  
Standard InCHIKey:  HCBLDZZFUFWBIT-NCVYMDLJSA-N
Standard InCHI:  InChI=1S/C34H46N10O8/c1-20(27(47)39-17-12-22-4-8-24(45)9-5-22)43-29(49)34(52)26(14-19-42-32(37)38)33(51,15-3-16-41-31(35)36)30(50)44(34)21(2)28(48)40-18-13-23-6-10-25(46)11-7-23/h4-13,17-18,20-21,26,45-46,51-52H,3,14-16,19H2,1-2H3,(H,39,47)(H,40,48)(H,43,49)(H4,35,36,41)(H4,37,38,42)/b17-12+,18-13+/t20-,21-,26+,33-,34-/m0/s1
SMILES:  C[C@@H](C(=N/C=C/c1ccc(cc1)O)O)N=C([C@]1([C@H](CCNC(=N)N)[C@@](CCCNC(=N)N)(C(=O)N1[C@@H](C)C(=N/C=C/c1ccc(cc1)O)O)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL443365
PubChem CID:   23427641
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000264] Organic acids and derivatives
      • [CHEMONTID:0000265] Carboxylic acids and derivatives
        • [CHEMONTID:0000013] Amino acids, peptides, and analogues
          • [CHEMONTID:0000348] Peptides
            • [CHEMONTID:0004830] Dipeptides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32717 anchinoe tenacior Species Hymedesmiidae Eukaryota n.a. Mediterranean n.a. PMID[7798957]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT6127 Individual Protein Bradykinin B1 receptor Homo sapiens Activity = 35.0 % PMID[543424]
NPT2 Others Unspecified Activity = 35.0 % PMID[543424]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC170302 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC475564
1.0 High Similarity NPC475409
0.9875 High Similarity NPC473546
0.8353 Intermediate Similarity NPC280022
0.8314 Intermediate Similarity NPC475532
0.8266 Intermediate Similarity NPC165285
0.814 Intermediate Similarity NPC129486
0.8129 Intermediate Similarity NPC61004
0.8125 Intermediate Similarity NPC119652
0.8125 Intermediate Similarity NPC97526
0.8092 Intermediate Similarity NPC198254
0.8092 Intermediate Similarity NPC274198
0.8092 Intermediate Similarity NPC276506
0.8057 Intermediate Similarity NPC17698
0.8043 Intermediate Similarity NPC477638
0.8043 Intermediate Similarity NPC477632
0.8022 Intermediate Similarity NPC61332
0.8022 Intermediate Similarity NPC240130
0.7933 Intermediate Similarity NPC473404
0.7912 Intermediate Similarity NPC94862
0.791 Intermediate Similarity NPC196243
0.7892 Intermediate Similarity NPC302715
0.7874 Intermediate Similarity NPC328649
0.7869 Intermediate Similarity NPC102959
0.7857 Intermediate Similarity NPC56685
0.7853 Intermediate Similarity NPC471165
0.7826 Intermediate Similarity NPC60516
0.7759 Intermediate Similarity NPC63931
0.7746 Intermediate Similarity NPC241794
0.7742 Intermediate Similarity NPC477631
0.7737 Intermediate Similarity NPC477551
0.773 Intermediate Similarity NPC477636
0.7717 Intermediate Similarity NPC96275
0.7713 Intermediate Similarity NPC329295
0.7709 Intermediate Similarity NPC50016
0.7688 Intermediate Similarity NPC475544
0.7688 Intermediate Similarity NPC469243
0.768 Intermediate Similarity NPC153554
0.7674 Intermediate Similarity NPC326349
0.7674 Intermediate Similarity NPC323336
0.7665 Intermediate Similarity NPC16188
0.7661 Intermediate Similarity NPC476268
0.7647 Intermediate Similarity NPC202198
0.764 Intermediate Similarity NPC328494
0.7634 Intermediate Similarity NPC51047
0.7632 Intermediate Similarity NPC477552
0.7632 Intermediate Similarity NPC477550
0.763 Intermediate Similarity NPC244336
0.7619 Intermediate Similarity NPC477639
0.7598 Intermediate Similarity NPC248670
0.7593 Intermediate Similarity NPC267237
0.7586 Intermediate Similarity NPC114806
0.7584 Intermediate Similarity NPC475204
0.7584 Intermediate Similarity NPC475123
0.7576 Intermediate Similarity NPC476989
0.7558 Intermediate Similarity NPC473580
0.7557 Intermediate Similarity NPC223207
0.7556 Intermediate Similarity NPC26108
0.753 Intermediate Similarity NPC168861
0.7529 Intermediate Similarity NPC473491
0.7529 Intermediate Similarity NPC24617
0.7515 Intermediate Similarity NPC214988
0.7514 Intermediate Similarity NPC290755
0.7514 Intermediate Similarity NPC304074
0.7514 Intermediate Similarity NPC471771
0.75 Intermediate Similarity NPC273755
0.7487 Intermediate Similarity NPC246591
0.7486 Intermediate Similarity NPC46009
0.7485 Intermediate Similarity NPC233702
0.7461 Intermediate Similarity NPC469443
0.7457 Intermediate Similarity NPC244509
0.7442 Intermediate Similarity NPC5194
0.7442 Intermediate Similarity NPC261934
0.7442 Intermediate Similarity NPC262166
0.7432 Intermediate Similarity NPC45037
0.743 Intermediate Similarity NPC66490
0.741 Intermediate Similarity NPC48202
0.7407 Intermediate Similarity NPC470728
0.7403 Intermediate Similarity NPC137627
0.7389 Intermediate Similarity NPC40234
0.7382 Intermediate Similarity NPC80514
0.7374 Intermediate Similarity NPC302597
0.7374 Intermediate Similarity NPC478005
0.7353 Intermediate Similarity NPC311658
0.7351 Intermediate Similarity NPC477637
0.7348 Intermediate Similarity NPC89831
0.7337 Intermediate Similarity NPC269750
0.7337 Intermediate Similarity NPC194671
0.7308 Intermediate Similarity NPC306804
0.7278 Intermediate Similarity NPC141957
0.7278 Intermediate Similarity NPC107938
0.7278 Intermediate Similarity NPC294516
0.7278 Intermediate Similarity NPC326241
0.7273 Intermediate Similarity NPC294951
0.7268 Intermediate Similarity NPC279871
0.7268 Intermediate Similarity NPC473354
0.7236 Intermediate Similarity NPC220060
0.7222 Intermediate Similarity NPC254700
0.72 Intermediate Similarity NPC469444
0.7184 Intermediate Similarity NPC300443
0.7174 Intermediate Similarity NPC473402
0.7174 Intermediate Similarity NPC158277
0.7158 Intermediate Similarity NPC230611
0.715 Intermediate Similarity NPC478007
0.7135 Intermediate Similarity NPC62104
0.7135 Intermediate Similarity NPC1390
0.7094 Intermediate Similarity NPC469445
0.709 Intermediate Similarity NPC471048
0.709 Intermediate Similarity NPC471050
0.709 Intermediate Similarity NPC471049
0.7083 Intermediate Similarity NPC163961
0.7083 Intermediate Similarity NPC473305
0.7081 Intermediate Similarity NPC136797
0.7081 Intermediate Similarity NPC478008
0.7081 Intermediate Similarity NPC155506
0.7081 Intermediate Similarity NPC159767
0.7081 Intermediate Similarity NPC476227
0.7074 Intermediate Similarity NPC476321
0.7065 Intermediate Similarity NPC194699
0.7065 Intermediate Similarity NPC219350
0.7053 Intermediate Similarity NPC299806
0.7048 Intermediate Similarity NPC326966
0.7041 Intermediate Similarity NPC313694
0.7041 Intermediate Similarity NPC242159
0.7037 Intermediate Similarity NPC471526
0.6995 Remote Similarity NPC209463
0.6978 Remote Similarity NPC22883
0.6978 Remote Similarity NPC210377
0.6978 Remote Similarity NPC217804
0.6978 Remote Similarity NPC5719
0.6977 Remote Similarity NPC328924
0.6965 Remote Similarity NPC81845
0.694 Remote Similarity NPC15068
0.6927 Remote Similarity NPC469442
0.6927 Remote Similarity NPC277306
0.6923 Remote Similarity NPC191863
0.6923 Remote Similarity NPC133470
0.6923 Remote Similarity NPC289776
0.6919 Remote Similarity NPC251439
0.6919 Remote Similarity NPC323662
0.6902 Remote Similarity NPC63040
0.6889 Remote Similarity NPC324850
0.6888 Remote Similarity NPC65714
0.6882 Remote Similarity NPC64205
0.6878 Remote Similarity NPC295795
0.6869 Remote Similarity NPC323244
0.686 Remote Similarity NPC25539
0.685 Remote Similarity NPC473450
0.6818 Remote Similarity NPC473371
0.6789 Remote Similarity NPC475421
0.6788 Remote Similarity NPC138083
0.6786 Remote Similarity NPC473378
0.6786 Remote Similarity NPC473407
0.6784 Remote Similarity NPC471592
0.6784 Remote Similarity NPC109580
0.6776 Remote Similarity NPC73655
0.676 Remote Similarity NPC122590
0.6758 Remote Similarity NPC319320
0.6758 Remote Similarity NPC287757
0.6735 Remote Similarity NPC283207
0.6728 Remote Similarity NPC283760
0.6726 Remote Similarity NPC325651
0.6725 Remote Similarity NPC118099
0.6725 Remote Similarity NPC474787
0.6725 Remote Similarity NPC151706
0.6725 Remote Similarity NPC90194
0.6725 Remote Similarity NPC260045
0.6725 Remote Similarity NPC293377
0.6725 Remote Similarity NPC9687
0.6725 Remote Similarity NPC474811
0.6725 Remote Similarity NPC79465
0.6725 Remote Similarity NPC476102
0.6725 Remote Similarity NPC475318
0.6725 Remote Similarity NPC49577
0.6725 Remote Similarity NPC76785
0.6725 Remote Similarity NPC273907
0.6725 Remote Similarity NPC474855
0.6725 Remote Similarity NPC475598
0.672 Remote Similarity NPC477462
0.6717 Remote Similarity NPC328763
0.6703 Remote Similarity NPC472923
0.6703 Remote Similarity NPC297145
0.6703 Remote Similarity NPC197743
0.6701 Remote Similarity NPC235194
0.6684 Remote Similarity NPC470112
0.6684 Remote Similarity NPC234069
0.6684 Remote Similarity NPC186617
0.6684 Remote Similarity NPC470903
0.6684 Remote Similarity NPC167763
0.6667 Remote Similarity NPC39822
0.665 Remote Similarity NPC64140
0.665 Remote Similarity NPC174122
0.6649 Remote Similarity NPC196091
0.6649 Remote Similarity NPC471568
0.6649 Remote Similarity NPC473693
0.6649 Remote Similarity NPC22014
0.6648 Remote Similarity NPC7817
0.6648 Remote Similarity NPC475168
0.6647 Remote Similarity NPC132636
0.6636 Remote Similarity NPC473317

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC170302 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8235 Intermediate Similarity NPD8303 Discontinued
0.7751 Intermediate Similarity NPD7523 Phase 3
0.7556 Intermediate Similarity NPD5200 Clinical (unspecified phase)
0.754 Intermediate Similarity NPD7617 Discontinued
0.7529 Intermediate Similarity NPD8019 Approved
0.7429 Intermediate Similarity NPD7495 Discontinued
0.7371 Intermediate Similarity NPD7118 Clinical (unspecified phase)
0.7294 Intermediate Similarity NPD7066 Clinical (unspecified phase)
0.7219 Intermediate Similarity NPD6809 Clinical (unspecified phase)
0.7219 Intermediate Similarity NPD8076 Discontinued
0.7102 Intermediate Similarity NPD6670 Clinical (unspecified phase)
0.7029 Intermediate Similarity NPD5348 Clinical (unspecified phase)
0.6948 Remote Similarity NPD8292 Phase 2
0.6914 Remote Similarity NPD8290 Clinical (unspecified phase)
0.6907 Remote Similarity NPD6836 Approved
0.6893 Remote Similarity NPD6078 Clinical (unspecified phase)
0.6893 Remote Similarity NPD7303 Discontinued
0.6869 Remote Similarity NPD7282 Approved
0.686 Remote Similarity NPD7450 Phase 2
0.6842 Remote Similarity NPD6901 Phase 3
0.6821 Remote Similarity NPD7978 Discontinued
0.6798 Remote Similarity NPD7613 Discontinued
0.6791 Remote Similarity NPD5137 Approved
0.6786 Remote Similarity NPD4497 Clinical (unspecified phase)
0.6765 Remote Similarity NPD4791 Clinical (unspecified phase)
0.6738 Remote Similarity NPD4652 Approved
0.6686 Remote Similarity NPD3136 Phase 2
0.6686 Remote Similarity NPD4782 Clinical (unspecified phase)
0.6684 Remote Similarity NPD6835 Approved
0.6684 Remote Similarity NPD8022 Clinical (unspecified phase)
0.6647 Remote Similarity NPD3632 Clinical (unspecified phase)
0.6647 Remote Similarity NPD1330 Phase 2
0.6647 Remote Similarity NPD1329 Clinical (unspecified phase)
0.6618 Remote Similarity NPD8162 Phase 2
0.6618 Remote Similarity NPD8163 Clinical (unspecified phase)
0.6615 Remote Similarity NPD6237 Clinical (unspecified phase)
0.6613 Remote Similarity NPD8031 Discontinued
0.6613 Remote Similarity NPD5218 Approved
0.6613 Remote Similarity NPD5219 Approved
0.6609 Remote Similarity NPD6866 Clinical (unspecified phase)
0.6609 Remote Similarity NPD6867 Clinical (unspecified phase)
0.6607 Remote Similarity NPD7451 Discontinued
0.6596 Remote Similarity NPD7485 Phase 3
0.6596 Remote Similarity NPD7484 Phase 3
0.6591 Remote Similarity NPD5341 Clinical (unspecified phase)
0.6561 Remote Similarity NPD7608 Discontinued
0.6546 Remote Similarity NPD5027 Approved
0.6546 Remote Similarity NPD5031 Approved
0.6546 Remote Similarity NPD5029 Approved
0.6533 Remote Similarity NPD7283 Approved
0.6532 Remote Similarity NPD8643 Discontinued
0.6531 Remote Similarity NPD5946 Clinical (unspecified phase)
0.6528 Remote Similarity NPD7695 Clinical (unspecified phase)
0.6524 Remote Similarity NPD2098 Approved
0.6517 Remote Similarity NPD6676 Phase 2
0.6514 Remote Similarity NPD7728 Clinical (unspecified phase)
0.6513 Remote Similarity NPD5032 Approved
0.6512 Remote Similarity NPD5729 Clinical (unspecified phase)
0.6509 Remote Similarity NPD5339 Clinical (unspecified phase)
0.65 Remote Similarity NPD6682 Clinical (unspecified phase)
0.6465 Remote Similarity NPD5038 Approved
0.6465 Remote Similarity NPD5037 Approved
0.645 Remote Similarity NPD3055 Approved
0.645 Remote Similarity NPD3053 Approved
0.6436 Remote Similarity NPD4521 Clinical (unspecified phase)
0.6429 Remote Similarity NPD4955 Approved
0.6429 Remote Similarity NPD5034 Approved
0.6429 Remote Similarity NPD4954 Approved
0.6429 Remote Similarity NPD5026 Approved
0.6429 Remote Similarity NPD5028 Approved
0.6429 Remote Similarity NPD36 Approved
0.6419 Remote Similarity NPD8405 Clinical (unspecified phase)
0.6418 Remote Similarity NPD5968 Phase 3
0.6417 Remote Similarity NPD2097 Approved
0.6414 Remote Similarity NPD5036 Approved
0.6406 Remote Similarity NPD6796 Discontinued
0.6404 Remote Similarity NPD6681 Discovery
0.64 Remote Similarity NPD2568 Approved
0.64 Remote Similarity NPD8172 Phase 2
0.64 Remote Similarity NPD5314 Approved
0.64 Remote Similarity NPD8173 Phase 2
0.6393 Remote Similarity NPD7131 Phase 3
0.6391 Remote Similarity NPD5311 Approved
0.6391 Remote Similarity NPD5310 Approved
0.6391 Remote Similarity NPD3125 Approved
0.639 Remote Similarity NPD7565 Approved
0.6379 Remote Similarity NPD6346 Approved
0.6378 Remote Similarity NPD5030 Phase 2
0.6369 Remote Similarity NPD6860 Clinical (unspecified phase)
0.6369 Remote Similarity NPD2561 Approved
0.6369 Remote Similarity NPD2562 Approved
0.6364 Remote Similarity NPD3555 Approved
0.6364 Remote Similarity NPD3552 Approved
0.6364 Remote Similarity NPD3554 Approved
0.6364 Remote Similarity NPD3553 Approved
0.6343 Remote Similarity NPD4757 Clinical (unspecified phase)
0.6321 Remote Similarity NPD3803 Clinical (unspecified phase)
0.6318 Remote Similarity NPD6377 Clinical (unspecified phase)
0.6316 Remote Similarity NPD8245 Clinical (unspecified phase)
0.6313 Remote Similarity NPD5035 Approved
0.6294 Remote Similarity NPD5192 Clinical (unspecified phase)
0.629 Remote Similarity NPD8417 Discontinued
0.6286 Remote Similarity NPD3059 Approved
0.6286 Remote Similarity NPD3062 Approved
0.6286 Remote Similarity NPD3061 Approved
0.6286 Remote Similarity NPD8416 Discontinued
0.6281 Remote Similarity NPD6557 Phase 2
0.6277 Remote Similarity NPD7972 Discontinued
0.6276 Remote Similarity NPD5190 Phase 2
0.6269 Remote Similarity NPD8025 Phase 2
0.6269 Remote Similarity NPD8051 Clinical (unspecified phase)
0.6265 Remote Similarity NPD5303 Approved
0.6265 Remote Similarity NPD5304 Approved
0.6264 Remote Similarity NPD4619 Approved
0.6264 Remote Similarity NPD4621 Approved
0.625 Remote Similarity NPD2017 Approved
0.625 Remote Similarity NPD2889 Approved
0.625 Remote Similarity NPD2888 Approved
0.625 Remote Similarity NPD2890 Approved
0.6243 Remote Similarity NPD7979 Clinical (unspecified phase)
0.6233 Remote Similarity NPD6189 Approved
0.6233 Remote Similarity NPD6188 Approved
0.6229 Remote Similarity NPD7086 Phase 2
0.6224 Remote Similarity NPD4603 Phase 2
0.6224 Remote Similarity NPD42 Phase 2
0.6224 Remote Similarity NPD6042 Phase 2
0.622 Remote Similarity NPD6863 Phase 2
0.6219 Remote Similarity NPD6089 Clinical (unspecified phase)
0.6207 Remote Similarity NPD5525 Clinical (unspecified phase)
0.6205 Remote Similarity NPD5033 Approved
0.6205 Remote Similarity NPD5605 Phase 2
0.6196 Remote Similarity NPD2874 Phase 2
0.6196 Remote Similarity NPD6419 Discontinued
0.6196 Remote Similarity NPD3536 Discontinued
0.619 Remote Similarity NPD6480 Clinical (unspecified phase)
0.6188 Remote Similarity NPD2458 Approved
0.6188 Remote Similarity NPD2459 Approved
0.6188 Remote Similarity NPD2460 Phase 3
0.6186 Remote Similarity NPD6187 Approved
0.6186 Remote Similarity NPD7827 Phase 1
0.6184 Remote Similarity NPD5856 Discontinued
0.6175 Remote Similarity NPD7554 Discontinued
0.6172 Remote Similarity NPD6256 Approved
0.6172 Remote Similarity NPD6255 Approved
0.6172 Remote Similarity NPD6254 Approved
0.6171 Remote Similarity NPD601 Approved
0.6171 Remote Similarity NPD597 Approved
0.6171 Remote Similarity NPD2028 Clinical (unspecified phase)
0.6171 Remote Similarity NPD598 Approved
0.617 Remote Similarity NPD2469 Approved
0.617 Remote Similarity NPD2541 Clinical (unspecified phase)
0.617 Remote Similarity NPD2468 Approved
0.617 Remote Similarity NPD7193 Clinical (unspecified phase)
0.617 Remote Similarity NPD6072 Discontinued
0.6163 Remote Similarity NPD4104 Clinical (unspecified phase)
0.6163 Remote Similarity NPD4103 Phase 2
0.6162 Remote Similarity NPD6297 Approved
0.6162 Remote Similarity NPD4186 Clinical (unspecified phase)
0.6159 Remote Similarity NPD2229 Approved
0.6159 Remote Similarity NPD2228 Approved
0.6159 Remote Similarity NPD2234 Approved
0.6158 Remote Similarity NPD5967 Approved
0.6149 Remote Similarity NPD5263 Approved
0.6146 Remote Similarity NPD4466 Phase 1
0.6136 Remote Similarity NPD1132 Approved
0.6136 Remote Similarity NPD1130 Approved
0.6136 Remote Similarity NPD1136 Approved
0.6132 Remote Similarity NPD6807 Phase 3
0.6126 Remote Similarity NPD4565 Clinical (unspecified phase)
0.6126 Remote Similarity NPD4564 Clinical (unspecified phase)
0.6124 Remote Similarity NPD6253 Approved
0.612 Remote Similarity NPD7910 Clinical (unspecified phase)
0.6119 Remote Similarity NPD6851 Approved
0.6119 Remote Similarity NPD6556 Clinical (unspecified phase)
0.6119 Remote Similarity NPD6853 Approved
0.6116 Remote Similarity NPD4086 Phase 1
0.6114 Remote Similarity NPD6919 Clinical (unspecified phase)
0.6111 Remote Similarity NPD4173 Approved
0.6111 Remote Similarity NPD5557 Phase 1
0.6111 Remote Similarity NPD3879 Approved
0.6111 Remote Similarity NPD3175 Clinical (unspecified phase)
0.6111 Remote Similarity NPD4172 Approved
0.6099 Remote Similarity NPD2209 Approved
0.6099 Remote Similarity NPD2211 Approved
0.6094 Remote Similarity NPD8070 Approved
0.6091 Remote Similarity NPD3909 Discontinued
0.6082 Remote Similarity NPD3073 Approved
0.6082 Remote Similarity NPD3286 Discontinued
0.6082 Remote Similarity NPD3071 Approved
0.6082 Remote Similarity NPD3072 Approved
0.608 Remote Similarity NPD5445 Approved
0.6073 Remote Similarity NPD7980 Clinical (unspecified phase)
0.607 Remote Similarity NPD7280 Phase 3
0.607 Remote Similarity NPD7281 Phase 3
0.6067 Remote Similarity NPD7113 Clinical (unspecified phase)
0.6066 Remote Similarity NPD5481 Discontinued
0.6066 Remote Similarity NPD4971 Clinical (unspecified phase)
0.6065 Remote Similarity NPD3878 Approved
0.6054 Remote Similarity NPD7892 Clinical (unspecified phase)
0.6053 Remote Similarity NPD3589 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data